slide1 l.
Skip this Video
Download Presentation
JFDA & HAI Workshop Towards equitable and affordable medicine prices policy in Jordan 4-5 December 2007

Loading in 2 Seconds...

play fullscreen
1 / 21

JFDA & HAI Workshop Towards equitable and affordable medicine prices policy in Jordan 4-5 December 2007 - PowerPoint PPT Presentation

  • Uploaded on

JFDA & HAI Workshop Towards equitable and affordable medicine prices policy in Jordan 4-5 December 2007. Strategies to increase the use of low priced quality generics. بسم الله الرحمن الرحيم Jordan Food and Drug Administration Drug Director Pharmacist Laila Ghazi Jarrar.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'JFDA & HAI Workshop Towards equitable and affordable medicine prices policy in Jordan 4-5 December 2007' - issac

Download Now An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
JFDA & HAI WorkshopTowards equitable and affordable medicine prices policy in Jordan4-5 December 2007

Strategies to increase the use of low priced quality generics

jordan food and drug administration drug director pharmacist laila ghazi jarrar

بسم الله الرحمن الرحيمJordan Food and Drug AdministrationDrug DirectorPharmacist Laila Ghazi Jarrar

drug directorate mission
Drug Directorate Mission

Drug Directorate is part of the JFDA which is an independent public sector regulatory institution whose main objectives are to ensure:-

  • that drugs are safe, efficacious and of good quality.
  • the safety of products including infants milk formula and their special formula, supplementary food, medicinal plants, natural products, disinfectants and detergents, medical equipment and supplies, pharmaceutical preparations containing vitamins and minerals, cosmetic preparations and any other substances related to treatment or cure of human beings from diseases.

The Directorate strives to maintain a balance between the potential health benefits and risks posed by all drugs and health products

drug directorate
Drug Directorate
  • The Drug Directorate was founded year 1973 as one of the Ministry of Health’s main departments, Since then it pursued it’s obligations in compliance with the effective Drug & Pharmacy law.
  • Drug Directorate works on providing and maintaining proper public health through allocating all possible means and tools to obtain both innovative and generic medicines within a reasonable period of time after ensuring their safety, quality and efficacy.
drug directorate5
Drug Directorate
  • Regulation by the JFDA of the marketing, manufacture and distribution of medicinal products plays a very significant role in ensuring that appropriate standards are maintained in this sector. This includes post marketing surveillance, which encompasses pharmacovigilance, investigation of reports of quality defects, and a programme of sampling and analysis (drug Test Bylaw # 48 year 2006).
  • So Drug Directorate is the only official body that is responsible of medicines which extends throughout the full lifecycle of all products from the starting from Active Pharmaceutical Ingredient until it is ready to be used by the patient as a Finished Product.
drug directorate6
Drug Directorate
  • Health professionals and consumers can be assured that JFDA-approved generic drugs have met the same rigid standards as the innovative. All generic drugs are put through a rigorous, multi-step review process that includes a review of scientific data on the generic drug's ingredients and performance.
laws bylaws guidelines http www jfda jo ar laws lawinfo aspx id 748
Laws, Bylaws & Guidelines

Drug & Pharmacy Law Stemming Criteria:-

Drug Registration Criteria

- Pharmacovigilance Criteria

- Monitoring of Raw material Criteria

Drug Pricing Criteria

Manufacturing Sites accreditation Criteria

Herbal Medicine Registration Criteria

Herbal Product Registration Criteria

Vitamins & Minerals Registration Criteria

Radiopharmaceuticals Registration Criteria

Medical Device Registration Criteria including Disinfectants & Detergents

Cosmetics & Cosmeceuticals Registration Criteria

Infants Milk Formula and their Special Formula

Biological, Vaccines & Sera Products Registration Criteria

Drug Testing Bylaw

drug directorate8
Drug Directorate

Includes 8 departments:-

  • Registration Department

(Registration Unit, Medical Device & Cosmetics Unit,

Pharmacovigilance Unit, Herbal Medicines Unit)

  • Pricing Department
  • Inspection & Monitoring Department

(Pharmacies & Drug Stores Unit, Manufacturing Sites Unit, Quality Control Unit)

  • Clinical Studies Department
  • Rational Drug Use Department
  • Narcotic and Psychotropic Substance Control
  • Import Department
  • Export Department
drug directorate9
Drug Directorate
  • A major strength in managing JFDA is the scientific expertise available to us from several technical committees assigned by the Drug & Pharmacy law #80 and composed of highly qualified technical scientists from both, public and private sectors.
  • JFDA will continue to utilize this to the best advantage of all stakeholders and to develop a knowledge network of specialists available to advise JFDA in their relevant discipline.
drug directorate technical committees
Drug DirectorateTechnical Committees
  • Technical committee for the registration of new drugs.
  • Technical committee for the registration of generic drugs.      
  • Pricing committee.
  • Accreditation of manufacturing sites committee.
  • Medicinal plants and herbs committee.
  • Cosmetics committee
  • Vitamins & Minerals committee.
  • Vaccines and Sera committee.
  • Medical Devices committee.
  • Bioequivalence studies committee.
  • Clinical studies committee.
  • Re-registration of drugs.  

LAB Test



Approve Line of Production

Accreditation of pharmaceutical

sites committee


Approval of Bioequivalence Study

Bioequivalence studies committee

Approval of Bioequivalence Study

Bioequivalence studies committee


Approve Line of Production

Accreditation of pharmaceutical

sites committee

Post marketing


& Lab Test




Drug Pricing

Pricing committee


Ensuring the use of Quality Generics

Approval of :

Technical committee for the

registration of generic drugs


Active substance

Manufacturing process of the medicinal product


(Specifications, analytical procedures and analytical validation)




inspection department
Inspection Department

GMP mandatory for all pharmaceutical production and maintained by JFDA’s well trained inspectors.

  • Good manufacturing practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product..
  • Registration of a Manufacturing line of production only after ensuring that it is GMP compliant either through documentation or by inspection.( by JFDA inspectors).

To assure drug quality, since testing finished product only is not enough anymore.

registration department
Registration Department
  • Approving Bioequivalence * studies.

- A generic must contain the same active ingredients as the original formulation.

- It is considered bioequivalent to the brand name counterpart with respect to phamacokinetic and pharmacodynamic properties.

- It is identical in dose, strength, route of administration, safety, efficacy, and intended use.

  • Approving API/s.
  • Approving stability profile.

NB: Drugs should pass lab testing Carried by JFDA QCL prior to registration


Clinical Studies Department has been established to efficiently manage & facilitate all studies needed for granting marketing authorization for both Generics & NCE

Regarding clinical studies JFDA/CTU is considered leader in both regional & international levels since it implements all needed elements that ensure the safety and good health of the participating volunteers in any clinical study (therapeutic or non-therapeutic Bioequivalence ) those are:-

  • Provisional Law No. (97),For the Year 2001,Law of Clinical Studies
  • Institutional Review Board Committee IRB
  • Clinical Studies Committee
  • Authorization of the conducting authority
  • Advanced volunteers Data Base.
  • Inspection visits to ensure that CRO’s are complying with the requirements in terms of their license.
  • Signed consent form
  • Insurance contract
registration department post marketing role
Registration DepartmentPost Marketing Role

Monitoring post marketing side effects (Pharmacovigilance)

Pharmacovigilance unit works on collecting, monitoring, researching, assessing and evaluating information from healthcare providers, patients, local and international Pharmacovigilance centers on the adverse effects of medicines & medical devices with a view to:-

- identifying new information about hazards associated with medicines

- preventing harm to patients.

quality control lab pre post marketing role
Quality Control LabPre & Post Marketing Role
  • Drug Testing Bylaw #48 issued in year 2006 ensured good quality coverage through out the shelf life of drugs since drugs are susceptible for testing at any time unlike the former bylaw.
  • Also drugs should be tested for two consecutive years and for Seven consecutive batches after which drug will be tested three times yearly upon importation in addition to random sampling (computerized) from the shelves of different outlets (Public or Hospital Pharmacies & Drug stores)
pricing department
Pricing Department

Continuous revision of the Jordanian public prices of drugs taking into consideration the following:-

  • Changes in the currency exchange rates.
  • Changes in the factors used for calculating the Jordanian public prices of drugs.
  • Changes in the export prices of drugs to Saudi Arabia.
  • Reduction in the drug prices in its country of origin.
  • Reduction in the export price and/or drug prices in its country of origin specified in the imports invoice.
  • Reduction of the originator drug's price which is reflected on the reduction of its generics so as to maintain their prices less than or equal to 80% of the originator's new price.
import department
Import Department
  • Import department ensures that all imported drugs & JFDA licensed products including Raw Materials Comply with the legal requirements and specification upon which it was granted marketing authorization in Jordan.
  • Pharmacists audit invoices to verify the compliance of the following information:-
    • Name and address of the manufacturing company.
    • Invoice Number and date of issue.
    • Name and address of the importing party.
    • Name of the drug, its pharmaceutical form, the container and the concentration, determining if it were a Sample.
    • Batch Number, production and expiry date and its quantity.
    • Export currency and rate and method of imports based on Inco Terms.
    • Country of Origin prices of the Public, the ex-factory and the hospital wherever it may be applicable upon registration.
  • Issues import statistics which aids local drug manufacturers and drug importers to set their future plans.
export department
Export Department

Since the Jordanian pharmaceutical industry plays an important role in our national economy and labor market, it is an export driven industry providing high quality, safe and effective pharmaceuticals at affordable prices for millions of people world wide.JFDA board of directors decided to establish a new department specialized in drug exportation by way of resolution number 10 dated 23-2-2006.

Export Department duties & responsibilities:-

  • Issues export statistics which aids local manufacturers to set their future manufacturing plans.
  • This department will deal with all export measures and related matters.
  • Facilitate and handle all correspondence with the Jordanian pharmaceutical industry.
  • Follow and activate bilateral agreements between Jordan and other countries to maintain and develop new markets for our drug exports.

The Mosaic at St. Georges

Church in Madaba

The Treasury at Petra

Ajloun Castle.

The Temple of Artemis at Jerash

The Temple of Artemis at Jerash

The Temple of Artemis at Jerash

The Temple of Artemis at Jerash

Thank You

The Roman Theatre in Amman.

Qusair Amra.

The Fort at Aqaba

Shobak Castle

Ruins at Umm Qays

Karak Castle.